Discovery of potent dihydro-oxazinoquinolinone inhibitors of GuaB for the treatment of tuberculosis.
Zhou Y, Aliagas I, Wang S, Li CS, Liu Z, Bowman CM, Burdick DJ, Clark KR, Dening TJ, Flygare J, Ganti A, Girgis HS, Hanan EJ, Harris SF, Hu C, Kapadia SB, Koehler MFT, Lai T, Liang J, Liu X, Ma F, Mao J, Nicolai J, Sims J, Unhayaker S, Wai J, Wang X, Wu P, Xu Y, Yen CW, Zhang R, Elfert TF, Tan MW, Kofoed EM, Crawford TD.
Zhou Y, et al. Among authors: girgis hs.
Bioorg Med Chem Lett. 2025 Mar 1;117:130026. doi: 10.1016/j.bmcl.2024.130026. Epub 2024 Nov 12.
Bioorg Med Chem Lett. 2025.
PMID: 39536836